U.S. Water Utilities Stock News

In mid-June 2026, Crinetics Pharmaceuticals reported new clinical data at ENDO 2026 showing that oral atumelnant improved key biomarkers in congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome, while PALSONIFY (paltusotine) maintained biochemical control, symptom stability and generally favorable tolerability in acromegaly over periods of up to two years. Together, these results highlight Crinetics’ progress in building an endocrinology franchise that combines an already...

DoubleVerify Holdings (DV) recently introduced AI powered brand suitability reporting for YouTube Audio Ads, extending its post bid measurement tools into audio focused formats in a move that could influence how investors view the stock. See our latest analysis for DoubleVerify Holdings. The recent AI product launches arrive as DoubleVerify Holdings' share price has gained 16.23% over the past month but is still down 3.04% on a year to date share price return basis, while the 1 year total...

Zai Lab (ZLAB) stock is in focus after China’s National Medical Products Administration approved TIVDAK for adults with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy. See our latest analysis for Zai Lab. The NMPA approval for TIVDAK comes after a mixed stretch for Zai Lab, with the stock showing a 1-day share price return of 3.87% and a 7-day share price return of 7.58%, yet a 1-year total shareholder return that declined 56.36%. This suggests...

Century Communities recently expanded its footprint with new home offerings in Freeland, MI, a luxury gated project in Greenwood Village, CO, and the Cloverleaf community in South Austin, TX, all featuring its online homebuying platform and affiliate financing option. Together, these launches highlight Century Communities’ push into both affordable and high-end markets while deepening its use of fully digital transactions to sell and finance homes. We’ll now examine how this combination of...

Personalis (PSNL) stock is in focus after the company released new clinical data at the 2026 ASCO meeting, highlighting how its NeXT Personal test detects minimal residual disease across six solid tumor types. See our latest analysis for Personalis. The ASCO update comes after a sharp 53.93% 1 month share price return and a 37.50% 3 month share price return. The 1 year total shareholder return of 51.78% and very large 3 year total shareholder return indicate that momentum has been strong...

In recent months, Baxter International has completed the divestiture of its Kidney Care business and reported modest sales growth with improving operating cash flow, underscoring progress after its portfolio simplification. This tighter focus on a medtech and hospital-products platform with a large installed base and recurring consumables demand is sharpening attention on margin improvement and cash conversion across the remaining business. Next, we’ll explore how Baxter’s sharpened...

Wave Life Sciences (WVE) is back in focus after recent data updates on its RNA editing platform, where lead program WVE-006 for alpha-1 antitrypsin deficiency showed dose-responsive, durable editing and an encouraging safety profile. See our latest analysis for Wave Life Sciences. Despite the encouraging WVE-006 data, Wave Life Sciences’ recent share price return has been weak. The stock is at US$6.00 after a 90-day share price decline of 51.85% and a year to date decline of 62.38%, while the...

Vera Therapeutics (VERA) stock is in focus after the company reached agreement with the FDA on an earlier eGFR analysis for its ORIGIN 3 trial of atacicept in IgA nephropathy. See our latest analysis for Vera Therapeutics. At a share price of $34.24, Vera Therapeutics has seen the 7 day share price return rise 7.84%, although the 90 day share price return is down 12.92% and the year to date share price return is down 29.58%. The 1 year total shareholder return of 56.70% and 3 year total...

Leadership reshuffle puts focus on services, industrials and private equity advisory Piper Sandler Companies (PIPR) stock is in focus after the firm reshaped its investment banking leadership, appointing new co-heads for services and industrials and forming a dedicated private equity advisory group. The reorganization places Rob Parker and Tripp Griffin in charge of services and industrials investment banking. Experienced dealmakers Matt Sznewajs, John Tye and David Lee are set to lead the...

Cinemark Holdings recently reported Q4 2025 earnings of US$0.16 per share, falling short of the US$0.24 consensus estimate, although revenue slightly exceeded forecasts. This earnings miss, combined with a weak earnings outlook and a poorly ranked film and television production and distribution sector, highlights mounting pressure on Cinemark’s profitability expectations. Next, we will examine how Cinemark’s weaker-than-expected earnings and subdued industry outlook may influence the...

With the Dow Jones at record highs, oil prices at a three month low and SpaceX reshaping the conversation around enterprise AI with a US$60 billion deal for Anysphere, the backdrop for large US industrial and multinational blue chip stocks looks very different from just a few months ago. Add in a closely watched first Federal Reserve decision under Kevin Warsh and renewed attention on resilient S&P 500 earnings, and it becomes important to separate headlines from practical portfolio ideas...

Aeva Technologies recently announced a past agreement with Bendix Commercial Vehicle Systems to integrate its 4D LiDAR perception platform into future active safety and collision mitigation solutions for Class 8 trucks, alongside new deployments of its CityOS traffic intelligence platform in Fargo and an industrial sensing collaboration with SICK. Together, these moves highlight how Aeva’s FMCW-based 4D LiDAR is being adopted across commercial vehicles, smart infrastructure, and industrial...

Chimera Investment Corporation’s Board of Directors has declared its second-quarter 2026 cash dividend of US$0.45 per common share, payable on July 31, 2026 to shareholders of record and ex-dividend on June 30, maintaining the same level as the first quarter despite a prior earnings miss. This reaffirmed dividend, alongside shareholder approval of directors and the 2026 auditor, underscores management’s emphasis on sustaining cash returns and signaling confidence in the REIT’s dividend...

Allstate (ALL) stock is in focus after Keefe Bruyette downgraded the insurer to Market Perform, highlighting that growth in personal auto policies in force appears to have peaked and that monthly reporting will cease. See our latest analysis for Allstate. Despite the downgrade, Allstate’s recent share price performance has remained firm, with a 9.2% 90 day share price return and 9.5% year to date share price return. The 3 year total shareholder return of about 119% reflects sustained...

MillerKnoll (MLKN) is back in the spotlight after using Fulton Market Design Days 2026 to showcase an extensive lineup of new and refreshed products, along with fresh creative leadership at Herman Miller. See our latest analysis for MillerKnoll. For investors watching MillerKnoll, the recent design launches and leadership appointments come after a period where the share price return has been mixed, with a 30 day gain of 8.64% and a 90 day decline of 12.48%, while the 3 year total shareholder...

BlackRock (BLK) is back in focus after launching the iShares Bitcoin Premium Income ETF (Nasdaq: BITA), a new digital asset product that blends bitcoin exposure with an options-based monthly income approach. See our latest analysis for BlackRock. BlackRock’s recent BITA launch comes as the stock trades at US$1,052.23, with a 7 day share price return of 3.98% and a 90 day share price return of 8.67%. The 1 year total shareholder return of 10.84% points to momentum that has built over a longer...

Earlier this month, SentinelOne reported first-quarter fiscal 2027 results showing 21% year-over-year revenue growth and 23% growth in annual recurring revenue, alongside insider share sales by senior executives including CEO Tomer Weingarten conducted under pre-arranged trading and tax-withholding plans. At the same time, investor sentiment toward SentinelOne has been influenced less by these company-specific developments and more by a broader recovery in software stocks following lower...

GLOBALFOUNDRIES (GFS) stock is in focus after three new partnerships in AI-enabled chip design, silicon photonics and secure European manufacturing raised fresh questions about how the foundry’s model prices in technology and supply chain risk. See our latest analysis for GLOBALFOUNDRIES. Those partnerships have landed alongside a sharp swing in sentiment, with GLOBALFOUNDRIES posting a 90 day share price return of 88.14% and a 1 year total shareholder return of 118.32%, even after a 1 day...

Targa Resources (TRGP) has drawn fresh attention after recent share performance data showed a decline of about 4% over the past month, alongside a gain of roughly 9% over the past 3 months. See our latest analysis for Targa Resources. At a share price of $262.33, Targa Resources has seen short term momentum cool, with the 1 day share price return down 3.77% and the 30 day share price return down 3.55%. This comes even as the year to date share price return of 40.46% and the very strong 5 year...

Onto Innovation (ONTO) is back in focus after stronger customer uptake of its inspection tools, the launch of its Dragonfly G5 system with substantial orders, and a new Rigaku partnership including a planned equity stake. See our latest analysis for Onto Innovation. Onto Innovation’s recent news has arrived alongside strong share price momentum, with a 7 day share price return of 24.9%, a 90 day share price return of 70.88%, and a 1 year total shareholder return of 239.8%. This suggests...

Commvault Systems recently faced a securities class action lawsuit alleging misleading disclosures about annual recurring revenue growth and sales conditions after fiscal third quarter 2026 results fell short of prior guidance. At the same time, Commvault’s participation at the Pure Accelerate 2026 conference, including presentations by its President of Customer & Field Operations, highlights management’s effort to reinforce its data resilience positioning with enterprise customers. We’ll...

Coty (COTY) has moved to address recent challenges by rolling out its Coty Curated framework and reviewing its portfolio, while leaning into Gen Z interest in fragrance wardrobes and a resilient beauty market. See our latest analysis for Coty. Against that backdrop, Coty’s 7 day share price return of 5.67% contrasts with a year to date share price decline of 34.08% and a 1 year total shareholder return decline of 59.41%, suggesting recent interest has picked up after a tougher run. If you are...

Rivian Automotive, Inc. recently announced a partnership with ChargeScape, LLC to enroll its high-capacity EV batteries into utility managed-charging programs across North America, enabling drivers to opt into utility offerings that can lower charging costs while supporting grid stability. This move positions Rivian within an industry-owned charging infrastructure platform backed by major automakers and utilities, potentially deepening its role in grid services just as its mass-market R2 SUV...

BioMarin Pharmaceutical (BMRN) drew fresh attention after presenting new VOXZOGO and BMN 333 data at ENDO 2026, reinforcing its focus on rare bone growth disorders and raising new questions for investors. See our latest analysis for BioMarin Pharmaceutical. Against this backdrop, BioMarin Pharmaceutical’s 1 month share price return of 7.41% stands in contrast to a year to date share price decline of 6.39%. Over 3 years, the total shareholder return is down 42.21%, suggesting momentum has been...